12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 14 at 07:05 AMBJDX-9.65%PLRZ-4.11%
Polyrizon adopts new executive, director pay policy with bonus, equity capsPUBT·Jul 13 at 03:01 PMPLRZ-4.11%
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial | PLRZ Stock NewsStockTitan·Jul 1 at 10:32 PMPLRZ-4.11%
Polyrizon wins central IRB clearance to start first NASARIX allergy blocker human trialPUBT·Jun 29 at 07:44 AMPLRZ-4.11%
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial | PLRZ Stock NewsStockTitan·Jun 28 at 11:44 PMPLRZ-4.11%
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery PatentTip Ranks·Jun 17 at 03:28 PMPLRZ-4.11%
Polyrizon says U.S. publishes patent application for Trap & Target nasal drug delivery platformPUBT·Jun 17 at 07:15 AMPLRZ-4.11%
